World Equity Group Inc. acquired a new position in Centene Corporation (NYSE:CNC – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 8,334 shares of the company’s stock, valued at approximately $535,000.
Other hedge funds have also recently modified their holdings of the company. Arista Wealth Management LLC grew its holdings in Centene by 100.5% in the second quarter. Arista Wealth Management LLC now owns 12,307 shares of the company’s stock worth $790,000 after purchasing an additional 6,170 shares during the period. Everhart Financial Group Inc. purchased a new position in shares of Centene during the second quarter valued at approximately $306,000. Everpar Advisors LLC bought a new stake in shares of Centene in the 2nd quarter worth approximately $231,000. Valeo Financial Advisors LLC grew its stake in shares of Centene by 8.7% in the 2nd quarter. Valeo Financial Advisors LLC now owns 7,524 shares of the company’s stock worth $483,000 after buying an additional 602 shares during the last quarter. Finally, LifeGoal Investments LLC increased its position in Centene by 7.3% during the 2nd quarter. LifeGoal Investments LLC now owns 8,233 shares of the company’s stock valued at $528,000 after buying an additional 560 shares in the last quarter. Institutional investors own 93.63% of the company’s stock.
Centene Price Performance
NYSE:CNC opened at $66.51 on Tuesday. The firm has a market capitalization of $32.86 billion, a price-to-earnings ratio of -6.37, a PEG ratio of 0.35 and a beta of 1.08. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 1.15. The business has a 50 day simple moving average of $64.58 and a 200-day simple moving average of $51.10. Centene Corporation has a 1 year low of $25.23 and a 1 year high of $69.36.
Analyst Upgrades and Downgrades
Several research firms have commented on CNC. Jefferies Financial Group boosted their target price on Centene from $39.00 to $48.00 and gave the stock a “hold” rating in a report on Wednesday, April 29th. Royal Bank Of Canada lifted their price target on Centene from $70.00 to $71.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 9th. Robert W. Baird upped their price target on shares of Centene from $46.00 to $66.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 29th. Zacks Research raised shares of Centene from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, July 29th. Finally, Oppenheimer lifted their target price on shares of Centene from $58.00 to $67.00 and gave the stock an “outperform” rating in a report on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, ten have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $68.58.
View Our Latest Stock Report on CNC
Centene Company Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Read More
- Five stocks we like better than Centene
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
